Peter Richmond

Associate Professor, MB BS W.Aust., MRCP(UK), FRACP

Head of Division, Health and Medical Sciences, Paediatrics
Associate Professor, Health and Medical Sciences, Paediatrics

https://orcid.org/0000-0001-7562-7228

Emailpeter.richmond@uwa.edu.au

The University of Western Australia (M561), 35 Stirling Highway,
6009 Perth
Australia

Source: Scopus
Calculated using citation counts from Scopus for publications in the UWA Profiles and Research Repository

If you made any changes in Pure these will be visible here soon.

Personal profile

Research expertise keywords

Immunodeficiency
Vaccines
Paediatric immunisation
Meningococcal disease
Otitis media
Influenza

Fingerprint

Dive into the research topics where Peter Richmond is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

11 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

6204 Citations
41 h-Index
233 Article
15 Review article
4 Letter
3 Abstract
More

Bacterial Reservoirs in the Middle Ear of Otitis-prone Children Are Associated with Repeat Ventilation Tube Insertion
Seppanen, E. J., Thornton, R. B., North, H. J. D., Corscadden, K. J., Wiertsema, S. P., Vijayasekaran, S., Coates, H. L., Jacoby, P., Richmond, P. C. & Kirkham, L. A. S., Feb 2020, In : Pediatric Infectious Disease Journal. 39, 2, p. 91-96 6 p.
Research output: Contribution to journal › Article
BCG vaccination-induced emergency granulopoiesis provides rapid protection from neonatal sepsis
The EPIC Consortium*, 6 May 2020, In : Science Translational Medicine. 12, 542, eaax4517.
Research output: Contribution to journal › Article
5 Citations (Scopus)
Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea
Idoko, O. T., Smolen, K. K., Wariri, O., Imam, A., Shannon, C. P., Dibassey, T., Diray-Arce, J., Darboe, A., Strandmark, J., Ben-Othman, R., Odumade, O. A., McEnaney, K., Amenyogbe, N., Pomat, W. S., van Haren, S., Sanchez-Schmitz, G., Brinkman, R. R., Steen, H., Hancock, R. E. W., Tebbutt, S. J. & 6 others, Richmond, P. C., van den Biggelaar, A. H. J., Kollmann, T. R., Levy, O., Ozonoff, A. & Kampmann, B., 30 Apr 2020, In : Frontiers in Pediatrics. 8, 197.
Research output: Contribution to journal › Article

Open Access
2 Citations (Scopus)
Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine
Bayliss, J., Nissen, M., Prakash, D., Richmond, P., Oh, K-B. & Nolan, T., 23 Jun 2020, In : HUMAN VACCINES. p. 1-15 15 p.
Research output: Contribution to journal › Review article

Open Access
Developmental outcomes following vaccine-proximate febrile seizures in children
Deng, L., Wood, N., Macartney, K., Gold, M., Crawford, N., Buttery, J., Richmond, P. & Barton, B., 21 Jul 2020, In : Neurology. 95, 3, p. e226-e238
Research output: Contribution to journal › Article
1 Citation (Scopus)

3 Active
59 Finished

Round 8 - A bacterial therapy to prevent otitis media – preparing for first-in-human studies
Kirkham, L., Richmond, P., Fulurija, A., Seppanen, E. & Strickland, D.
Government of Western Australia, Department of Health
1/07/20 → 30/06/22
Project: Research
C2144 CTRA (sponsor USyd) related to NHMRC APP1158722
Richmond, P.
National Health & Medical Research Council NHMRC
1/04/20 → 31/12/23
Project: Research
Randomised controlled trial of mixed whole-cell/acellular pertussis vaccination versus acellular-only vaccination of infants
Richmond, P. & Marsh, J.
National Health & Medical Research Council NHMRC
1/01/20 → 31/12/23
Project: Research
RSV MAT-004: A Phase II observer-blind study to assess safety, reactogenicity, and immunogenicity of GSK Biologicals’ investigational RSV Maternal unadjuvanted vaccine (GSK3888550A), in healthy pregnant women and infants born to vaccinated mothers
Richmond, P.
GlaxoSmithKline
11/11/19 → 10/11/20
Project: Research
A study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on viral proteins encoded by chimpanzee-derived adenovector (ChAd155-RSV) (GSK3389245A) in infants.
Richmond, P.
GlaxoSmithKline
8/09/19 → 7/09/20
Project: Research